New Jersey 2024-2025 Regular Session

New Jersey Senate Bill SJR121 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	SENATE JOINT RESOLUTION No. 121 STATE OF NEW JERSEY 221st LEGISLATURE INTRODUCED JUNE 6, 2024
2	2
3	3	SENATE JOINT RESOLUTION
4	4
5	5	No. 121
6	6
7	7	STATE OF NEW JERSEY
8	8
9	9	221st LEGISLATURE
10	10
11	11
12	12
13	13	INTRODUCED JUNE 6, 2024
14	14
15	15
16	16
17	17	Sponsored by: Senator TROY SINGLETON District 7 (Burlington) SYNOPSIS Designates May 15 of each year as "Tuberous Sclerosis Complex Awareness Day" in New Jersey. CURRENT VERSION OF TEXT As introduced.
18	18
19	19
20	20
21	21	Sponsored by:
22	22
23	23	Senator TROY SINGLETON
24	24
25	25	District 7 (Burlington)
26	26
27	27
28	28
29	29
30	30
31	31
32	32
33	33
34	34
35	35	SYNOPSIS
36	36
37	37	Designates May 15 of each year as "Tuberous Sclerosis Complex Awareness Day" in New Jersey.
38	38
39	39
40	40
41	41	CURRENT VERSION OF TEXT
42	42
43	43	As introduced.
44	44
45	45
46	46
47	47	A Joint Resolution designating May 15 of each year as "Tuberous Sclerosis Complex Awareness Day" in New Jersey. Whereas, Tuberous Sclerosis is a rare genetic complex that affects multiple organ systems; and Whereas, Tuberous Sclerosis leads to irregularities in one of two protein-encoding genes which regulate cell division and growth, causing benign tumors to develop in the brain, heart, kidneys, eyes, and lungs; and Whereas, Triangular cortical tubers, or brain matter containing abnormal cells, appear in the fetus during pregnancy as characteristic of Tuberous Sclerosis; and Whereas, The atypical brain structures associated with Tuberous Sclerosis block the flow of cerebrospinal fluid to the brain and result in epilepsy and developmental delays; and Whereas, Nearly all individuals with Tuberous Sclerosis present with neuropsychiatric conditions, such as autism, attention deficit hyperactivity disorder, anxiety, depressive, impulsivity, and aggression; and Whereas, Over half of individuals with Tuberous Sclerosis Complex are diagnosed with autism; and Whereas, Tuberous Sclerosis Complex is a leading cause of epileptic seizures, specifically focal seizures, absence seizures, and myoclonic seizures; and Whereas, Skin lesions, hypopigmentation, and facial discoloration caused by Tuberous Sclerosis develop across the lifespan; and Whereas, Tuberous Sclerosis affects one million individuals around the world and 50,000 individuals in the United States; and Whereas, Currently, there is no medical cure for the condition; and Whereas, Organizations such as the TSC Alliance, Tuberous Sclerosis Complex International, and Tuberous Sclerosis Association convene to fund research, share information, and support families influenced by Tuberous Sclerosis; and Whereas, May 15 is recognized as global Tuberous Sclerosis Complex Awareness Day, designed to increase public awareness for Tuberous Sclerosis; and Whereas, It is fitting, proper, and in the public interest of this State to take action to increase recognition for this rare genetic condition; now, therefore, Be It Resolved by the Senate and General Assembly of the State of New Jersey: 1. May 15 of each year is designated as "Tuberous Sclerosis Complex Awareness Day" in New Jersey. 2. The Governor is respectfully requested to annually issue a proclamation recognizing May 15 as "Tuberous Sclerosis Complex Awareness Day" in New Jersey, and to call upon public officials and citizens of this State to observe the day with appropriate activities and programs. 3. This joint resolution shall take effect immediately. STATEMENT This joint resolution designates May 15 of each year as "Tuberous Sclerosis Complex Awareness Day" in New Jersey. Tuberous Sclerosis is a rare genetic complex that affects multiple organ systems. Tuberous Sclerosis leads to irregularities in one of two protein-encoding genes which regulate cell division and growth (TSC1 or TSC2), causing non-cancerous tumors to develop in different organs, primarily the brain, heart, kidneys, eyes, and lungs. The benign tumors and abnormal brain structures that are characteristic of Tuberous Sclerosis block the flow of cerebrospinal fluid to the brain and result in epilepsy, autism, attention deficit hyperactivity disorder, and various mood complexes. Tuberous Sclerosis is a leading cause of epileptic seizures. Sixty percent of those with Tuberous Sclerosis experience autism. Tuberous Sclerosis affects one million individuals around the world and 50,000 individuals in the United States. At least two children born each day in the United States have Tuberous Sclerosis. Currently, there is no medical cure for the condition. Strategic research will prioritize earlier diagnosis, therapies, and mechanisms for prevention. Organizations such as the TSC Alliance, Matthew's Friends, Tuberous Sclerosis Complex International, and Tuberous Sclerosis Association convene to fund such research and support families influenced by Tuberous Sclerosis. The Tuberous Sclerosis Alliance designates the Northeast Regional Epilepsy Group's Comprehensive Tuberous Sclerosis Clinic at Hackensack University Medical Center as a network clinic and referral center. May 15 is recognized as global Tuberous Sclerosis Complex Awareness Day, designed to increase public awareness for this rare condition. By amplifying the voices of individuals in the Tuberous Sclerosis community, the State may benefit from innovative treatment strategies and improved patient outcomes.
48	48
49	49	A Joint Resolution designating May 15 of each year as "Tuberous Sclerosis Complex Awareness Day" in New Jersey.
50	50
51	51
52	52
53	53	Whereas, Tuberous Sclerosis is a rare genetic complex that affects multiple organ systems; and
54	54
55	55	Whereas, Tuberous Sclerosis leads to irregularities in one of two protein-encoding genes which regulate cell division and growth, causing benign tumors to develop in the brain, heart, kidneys, eyes, and lungs; and
56	56
57	57	Whereas, Triangular cortical tubers, or brain matter containing abnormal cells, appear in the fetus during pregnancy as characteristic of Tuberous Sclerosis; and
58	58
59	59	Whereas, The atypical brain structures associated with Tuberous Sclerosis block the flow of cerebrospinal fluid to the brain and result in epilepsy and developmental delays; and
60	60
61	61	Whereas, Nearly all individuals with Tuberous Sclerosis present with neuropsychiatric conditions, such as autism, attention deficit hyperactivity disorder, anxiety, depressive, impulsivity, and aggression; and
62	62
63	63	Whereas, Over half of individuals with Tuberous Sclerosis Complex are diagnosed with autism; and
64	64
65	65	Whereas, Tuberous Sclerosis Complex is a leading cause of epileptic seizures, specifically focal seizures, absence seizures, and myoclonic seizures; and
66	66
67	67	Whereas, Skin lesions, hypopigmentation, and facial discoloration caused by Tuberous Sclerosis develop across the lifespan; and
68	68
69	69	Whereas, Tuberous Sclerosis affects one million individuals around the world and 50,000 individuals in the United States; and
70	70
71	71	Whereas, Currently, there is no medical cure for the condition; and
72	72
73	73	Whereas, Organizations such as the TSC Alliance, Tuberous Sclerosis Complex International, and Tuberous Sclerosis Association convene to fund research, share information, and support families influenced by Tuberous Sclerosis; and
74	74
75	75	Whereas, May 15 is recognized as global Tuberous Sclerosis Complex Awareness Day, designed to increase public awareness for Tuberous Sclerosis; and
76	76
77	77	Whereas, It is fitting, proper, and in the public interest of this State to take action to increase recognition for this rare genetic condition; now, therefore,
78	78
79	79
80	80
81	81	Be It Resolved by the Senate and General Assembly of the State of New Jersey:
82	82
83	83
84	84
85	85	1. May 15 of each year is designated as "Tuberous Sclerosis Complex Awareness Day" in New Jersey.
86	86
87	87
88	88
89	89	2. The Governor is respectfully requested to annually issue a proclamation recognizing May 15 as "Tuberous Sclerosis Complex Awareness Day" in New Jersey, and to call upon public officials and citizens of this State to observe the day with appropriate activities and programs.
90	90
91	91
92	92
93	93	3. This joint resolution shall take effect immediately.
94	94
95	95
96	96
97	97
98	98
99	99	STATEMENT
100	100
101	101
102	102
103	103	This joint resolution designates May 15 of each year as "Tuberous Sclerosis Complex Awareness Day" in New Jersey. Tuberous Sclerosis is a rare genetic complex that affects multiple organ systems. Tuberous Sclerosis leads to irregularities in one of two protein-encoding genes which regulate cell division and growth (TSC1 or TSC2), causing non-cancerous tumors to develop in different organs, primarily the brain, heart, kidneys, eyes, and lungs.
104	104
105	105	The benign tumors and abnormal brain structures that are characteristic of Tuberous Sclerosis block the flow of cerebrospinal fluid to the brain and result in epilepsy, autism, attention deficit hyperactivity disorder, and various mood complexes. Tuberous Sclerosis is a leading cause of epileptic seizures. Sixty percent of those with Tuberous Sclerosis experience autism.
106	106
107	107	Tuberous Sclerosis affects one million individuals around the world and 50,000 individuals in the United States. At least two children born each day in the United States have Tuberous Sclerosis.
108	108
109	109	Currently, there is no medical cure for the condition. Strategic research will prioritize earlier diagnosis, therapies, and mechanisms for prevention. Organizations such as the TSC Alliance, Matthew's Friends, Tuberous Sclerosis Complex International, and Tuberous Sclerosis Association convene to fund such research and support families influenced by Tuberous Sclerosis. The Tuberous Sclerosis Alliance designates the Northeast Regional Epilepsy Group's Comprehensive Tuberous Sclerosis Clinic at Hackensack University Medical Center as a network clinic and referral center.
110	110
111	111	May 15 is recognized as global Tuberous Sclerosis Complex Awareness Day, designed to increase public awareness for this rare condition. By amplifying the voices of individuals in the Tuberous Sclerosis community, the State may benefit from innovative treatment strategies and improved patient outcomes.